Ubp Investment Advisors Sa Amarin Corp Plcuk Transaction History

Ubp Investment Advisors Sa

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$5.03 - $8.8 $50,300 - $88,000	-10,000 Closed	0 $0
Q4 2020 Feb 23, 2021	SELL	$4.04 - $5.31 $24,240 - $31,859	-6,000 Reduced 37.5%	10,000 $49,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $24,240 - $31,859	6,000 Added 60.0%	16,000 $78,000
Q2 2020 Oct 22, 2020	BUY	$4.78 - $8.26 $47,470 - $82,030	9,931 Added 14392.75%	10,000 $69,000
Q2 2020 Aug 05, 2020	BUY	$4.78 - $8.26 $329 - $569	69 New	69 $10 Million
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $40,000 - $215,300	-10,000 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$13.94 - $24.12 $139,400 - $241,200	10,000 New	10,000 $214,000
Q3 2019 Nov 13, 2019	SELL	$13.89 - $23.16 $152,790 - $254,760	-11,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $48,810 - $61,530	-3,000 Reduced 21.43%	11,000 $213,000
Q1 2019 Apr 29, 2019	BUY	$12.61 - $22.33 $12,610 - $22,330	1,000 Added 7.69%	14,000 $291,000
Q4 2018 Feb 04, 2019	BUY	$12.41 - $22.98 $161,330 - $298,740	13,000 New	13,000 $177,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Ubp Investment Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Ubp Investment Advisors Sa with notifications on news.